Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock

Created at 4 Jun · 02:13 UTC1 source

IN SHORT

Spyre Therapeutics Chief Medical Officer Sheldon Sloan sold company stock valued at $624,975. The transaction involved shares of the biopharmaceutical firm.

Key Numbers

$624,975value of stock sold by CMO

Who's Involved

Sheldon Sloan

Chief Medical Officer of Spyre Therapeutics, sold company stock

Spyre Therapeutics

Biopharmaceutical company whose CMO sold stock

Key facts

Spyre Therapeutics CMO Sheldon Sloan sold company stock.
The value of the stock sold was $624,975.

Spyre Therapeutics Chief Medical Officer Sheldon Sloan has sold shares of the company's stock. The total value of the transaction amounted to $624,975. This sale represents a notable insider transaction within the biopharmaceutical firm.

↳ Why This Matters

Insider selling can sometimes signal a lack of confidence from company executives in future stock performance, potentially impacting investor sentiment.

FREQUENTLY ASKED

Sheldon Sloan is the Chief Medical Officer of Spyre Therapeutics.

He sold shares of Spyre Therapeutics stock.

The stock sale was valued at $624,975.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

CME Headlines

Amendments to the Daily Settlement Procedure Document for all 30-Year Uniform Mortgage-Backed Securities (UMBS) To-Be-Announced (TBA) Futures Contracts

Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock

PiQ Daily

Key facts

Get the newsletter.

Spyre Therapeutics CMO Sheldon Sloan sells $624,975 in stock

PiQ Daily

Key facts

Get the newsletter.